Download PDF - The Dermatologist
Download PDF - The Dermatologist
Download PDF - The Dermatologist
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FA L L C L I N I C A L D E R M AT O L O G Y C O N F E R E N C E P R O C E E D I N G S<br />
TREATING ACNE WITH ORAL<br />
CONTRACEPTIVES<br />
A GUIDE FOR SAFE, EFFECTIVE AND EFFICIENT PRESCRIBING<br />
BY JULIE C. HARPER, M.D.<br />
UNIVERSITY OF ALABAMA – BIRMINGHAM<br />
BIRMINGHAM, AL<br />
While some dermatologists<br />
have been prescribing<br />
oral contraceptives<br />
for the treatment of acne<br />
for many years with much success,<br />
others are resistant. <strong>The</strong><br />
goal of this article is to assure the<br />
safe, effective and efficient prescription<br />
of oral contraceptives for<br />
acne patients, which will result in<br />
Julie C. Harper, M.D. i m p rovements in patients’ acne<br />
and their overall quality of life.<br />
Acne is a complex multifactorial disord e r. Since there are<br />
4 diff e rent causes in the pathogenetic process, combination<br />
t reatments that target the multiple pathogenetic factors will<br />
o ffer the greatest improvement in the shortest amount of<br />
time. Oral contraceptives can be added to the armamentarium<br />
as another option for treatment.<br />
<strong>The</strong> 4 causes of acne are follicular epidermal hyperpro l i f e r a-<br />
tion, excess sebum, P ropionibacterium acnes and inflammation.<br />
During follicular epidermal hyperproliferation, plugging<br />
causes the development of comedones and micro c o m e d o n e s .<br />
For excess sebum, hormonal therapy, whether it is spiro n o l a c-<br />
tone, flutamide or oral contraceptives, creates an antiandro g e n<br />
e ffect that has most of its impact on the sebaceous gland.<br />
While probably not the first event in the pathogenetic pro c e s s ,<br />
P ropionibacterium acnes certainly is a cause. Also, whether or<br />
not inflammation is the first event in the process or it is secondary<br />
to P. acnes is a difficult question to answer.<br />
Oral contraceptives are not monotherapy for acne; rather,<br />
they fall into the mix of topical retinoids, benzoyl peroxides,<br />
and antibiotics. <strong>The</strong> type of oral contraceptive prescribed for<br />
acne is a combination of ethinyl estradiol and a progestin.<br />
Ethinyl estradiol varies in dose from pill to pill from 20 micrograms<br />
to 50 micrograms in a pill. <strong>The</strong> amount of ethinyl estradiol<br />
is important, because many of the risk factors associated<br />
with birth control pills are associated with higher doses of<br />
ethinyl estradiol. <strong>The</strong> progestins in combination birth control<br />
pills vary widely but may include norethindrone acetate, levonorgestrel,<br />
desogestrel, norgestimate, and drospirenone<br />
among others. Drospirenone is the only progestin available in<br />
the United States that is antiandrogenic alone. Some other<br />
progestins can be proandrogenic.<br />
Oral contraceptives are antiandrogenic because ethinyl<br />
estradiol in combination birth control pills increases sex hormone<br />
binding globulin. Sex hormone binding globulin acts as<br />
a sponge — it soaks up free testosterone and decreases the<br />
amount that is free and circulating and capable of having its<br />
impact at the sebaceous gland, for example. Also, there is a<br />
negative feedback to the hypothalamus and pituitary, which<br />
results in decreased production and release of gonadotropin<br />
releasing hormone, luteinizing hormone and follicle stimulating<br />
hormone. This then results in decreased ovarian production<br />
of hormone. Also, because ovulation is blocked, the ovary<br />
produces less androgen.<br />
<strong>The</strong> novel progestin, dro s p i renone, is equivalent to about<br />
25 mg of spironolactone when it is in a 3 mg dose, which<br />
is available in 2 birth control pills that are on the market now<br />
in the United States. Dro s p i renone has antimineralocorticoid<br />
properties as well.<br />
Attendees focus on new clinical information.<br />
1 2 • M A R C H 2 0 0 8 • S U P P L E M E N T T O S K I N & A G I N G